Riskpilot← Back to searchSign inGet full accessAZETA PHARMA AB
ABIn liquidationOrg 5593203739StockholmEconomic activity was not specified by tax authority · NACE 0000Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
Equity ratio
41.2%
Financial strength
Net profit 2025
SEK -36K
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -36K | — |
| Net profit | SEK -36K | — |
| Total assets | SEK 34K | -32% |
| Equity | SEK 14K | -72% |
| Employees | 0 | — |
Legal name
AZETA PHARMA AB
Org number
5593203739
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
2 juni 2021
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn likvidatorsuppleanten externa firmatecknarna
Company purpose
Bolagets verksamhet ska vara att bedriva import, export samt handel med apoteksvaror, egenvårdsprodukter (OTC-läkemedel) och receptförskrivna läkemedel samt därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | — | — | — | −36 |
| Depreciation & amort. | — | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | 0 | −36 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 0 | −36 |
| Tax | — | −0 | −0 | −0 | −0 |
| Net profit | — | 0 | 0 | 0 | −36 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | — | 50 | 50 | 50 | 34 |
| Equity | — | 50 | 50 | 50 | 14 |
| Long-term debt | — | 0 | 0 | 0 | 0 |
| Short-term debt | — | 0 | 0 | 0 | 20 |
| Total debt | — | — | — | — | 20 |
EBITDA margin
-3600000.0%
This company
15.8%
Market median
-22784910% vs market
20212025
Equity ratio
41.2%
This company
38.2%
Market median
+8% vs market
20212025
Return on equity
-257.1%
This company
18.4%
Market median
-1497% vs market
20212025
Net profit margin
-3600000.0%
This company
8.1%
Market median
-44444544% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.43×
This company
0.62×
Market median
-131% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JA Liquidator | Liquidator | 2026 | — | — |
JL Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
AM External Signatory | External Signatory | 2026 | — | — |
GU Liquidator | Liquidator | 2026 | — | — |
WL Liquidator | Liquidator | 2026 | — | — |
AS External Signatory | External Signatory | 2026 | — | — |
AM External Signatory | External Signatory | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AZETA PHARMA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Anders Fredrik Lovén | Liquidator | 0 companies |
| Jenny Linnea Leijon | Authorized Recipient of Service | 0 companies |
| Anna Matilda Sjödin | External Signatory | 0 companies |
| Gerd Ulla Marina Jonsson | Liquidator | 0 companies |
| Wendy Lissette Fahlgren | Liquidator | 0 companies |
| Anna Stina Hammarström | External Signatory | 0 companies |
| Aline Madeleine Pettersson | External Signatory | 0 companies |
| Jan Totte Dahlin | Board of Directors | 0 companies |
| Andrius Jurgelevicius | Board of Directors | 0 companies |
| Juste Levcenkaite | Board of Directors | 0 companies |
| Gintare Barysaite | Deputy Board Member | 0 companies |